Cargando…

Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas

BACKGROUND: Acromegaly is a rare disease primarily caused by growth hormone (GH)-secreting pituitary adenomas, and its treatment is costly. Moreover, some patients are unresponsive to treatment. Hence, there are increasing efforts to develop new drugs with improved effectiveness for this disease. BI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jean, Oh, Ju Hun, Harlem, Heather, Culler, Michael D., Ku, Cheol Ryong, Lee, Eun Jig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090307/ https://www.ncbi.nlm.nih.gov/pubmed/32207278 http://dx.doi.org/10.3803/EnM.2020.35.1.177

Ejemplares similares

OR06-02 TBR-760, a Chimeric Somatostatin-Dopamine Compound, Arrests Aggressive Non-Functioning Pituitary Adenoma Growth In Vivo
por: Halem, Heather A, et al.
Publicado: (2020)

Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma
por: Jung, Hyein, et al.
Publicado: (2021)

Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomas
por: Wang, Ji-wen, et al.
Publicado: (2014)

Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms
por: Cantone, Maria Celeste, et al.
Publicado: (2021)

TBR-760, a Dopamine-Somatostatin Compound, Arrests Growth of Aggressive Nonfunctioning Pituitary Adenomas in Mice
por: Halem, Heather A, et al.
Publicado: (2020)

Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant
por: Ku, Cheol Ryong, et al.
Publicado: (2021)

The role of somatostatin analogues in treatment of TSH secreting pituitary adenomas
por: Zgliczyński, Wojciech, et al.
Publicado: (2013)

Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

THU072 Association Between Nonalcoholic Fatty Liver Disease And Growth Hormone Deficiency In Patients With Nonfunctioning Pituitary Adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

Dopamine Agonists for Pituitary Adenomas
por: Cooper, Odelia, et al.
Publicado: (2018)

Gigantism caused by growth hormone secreting pituitary adenoma
por: Rhee, Noorisaem, et al.
Publicado: (2014)

THU553 Anti-tumor Effect Of Rosiglitazone Via Upregulating 15-PDGH In Prolactin Secreting Adenoma
por: Kang, Chan Woo, et al.
Publicado: (2023)

Outcome of Endoscopic Transsphenoidal Surgery in Combination with Somatostatin Analogues in Patients with Growth Hormone Producing Pituitary Adenoma
por: Zhou, Tao, et al.
Publicado: (2014)

Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?
por: Ku, Cheol Ryong, et al.
Publicado: (2020)

Dexamethasone suppression for (18)F-FDG PET/CT to localize ACTH-secreting pituitary tumors
por: Kim, Kyungwon, et al.
Publicado: (2023)

Clinical Relevance of New World Health Organization Classification System for Pituitary Adenomas: A Validation Study With 2-Year Experience
por: Hong, Seung Woo, et al.
Publicado: (2021)

In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells
por: Cuny, Thomas, et al.
Publicado: (2016)

Follicle-stimulating Hormone-secreting Pituitary Adenoma Accompanied by Painful Thyroiditis
por: Ichijo, Masashi, et al.
Publicado: (2019)

SAT-276 Co-Secreting TSH and Growth Hormone Pituitary Adenoma
por: Eid, Hatem
Publicado: (2020)

Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement
por: Peverelli, Erika, et al.
Publicado: (2015)

MON-467 Expression of Somatostatin Receptors in Aggressive Non-Functioning Pituitary Adenomas
por: Soto, Alfonso, et al.
Publicado: (2019)

Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma
por: Wang, Meng, et al.
Publicado: (2022)

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
por: Behling, Felix, et al.
Publicado: (2018)

Transformation of a Microprolactinoma into a Mixed Growth Hormone and Prolactin-Secreting Pituitary Adenoma
por: Dessimoz, Cédric, et al.
Publicado: (2012)

Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells
por: An, Jiayin, et al.
Publicado: (2017)

Ectopic Adrenocorticotropic Hormone-Secreting Pituitary Adenoma in the Clivus Region: A Case Report
por: Zhang, Yan, et al.
Publicado: (2022)

Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center
por: Liu, Jie, et al.
Publicado: (2022)

Investigation of Responsiveness to Thyrotropin-Releasing Hormone in Growth Hormone-Producing Pituitary Adenomas
por: Chin, Sang Ouk, et al.
Publicado: (2013)

Stereotactic Irradiation of GH-Secreting Pituitary Adenomas
por: Minniti, G., et al.
Publicado: (2012)

Synchronous GH- and prolactin-secreting pituitary adenomas
por: Rahman, Maryam, et al.
Publicado: (2014)

The risks of overlooking the diagnosis of secreting pituitary adenomas
por: Brue, Thierry, et al.
Publicado: (2016)

Clinically Functioning FSH-Secreting Pituitary Adenoma
por: AlNasrallah, Noor, et al.
Publicado: (2021)

Treatment of acromegaly by rosiglitazone via upregulating 15-PGDH in both pituitary adenoma and liver
por: Zhang, Yichao, et al.
Publicado: (2021)

Thyroid-Stimulating Hormone-Secreting Pituitary Adenomas : Single Institutional Experience of 14 Consecutive Cases
por: Byun, Joonho, et al.
Publicado: (2020)

Surgical management of growth hormone-secreting pituitary adenomas: A retrospective analysis of 33 patients
por: Zheng, Yong, et al.
Publicado: (2020)

In Vivo Characterization of Cortical and White Matter Microstructural Pathology in Growth Hormone-Secreting Pituitary Adenoma
por: Yuan, Taoyang, et al.
Publicado: (2021)

Uric acid levels correlate with disease activity in growth hormone-secreting pituitary adenoma patients
por: Mo, Caiyan, et al.
Publicado: (2023)

Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma)
por: Yu, Benxia, et al.
Publicado: (2017)

Surgical Outcome and Evaluation of Strategies in the Management of Growth Hormone-Secreting Pituitary Adenomas After Initial Transsphenoidal Pituitary Adenectomy Failure
por: Yan, Jiun-Lin, et al.
Publicado: (2022)

ODP286 A Case of Synchronous Growth Hormone and Adrenocorticotrophic Hormone Secretion in a Patient with an Incidental Pituitary Adenoma.
por: Maraqa, Sima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tmdjkf241hgi9h91bu6rqj8gn7